Author

Anfang Wu

Institutions: Mayo Clinic, Harvard University, Moffitt Cancer Center, Saint Vincent's Catholic Medical Center, Dana-Farber Cancer Institute, Celgene (United States)

Observed institutions: Mayo Clinic, Harvard University, Moffitt Cancer Center, Saint Vincent's Catholic Medical Center, Dana-Farber Cancer Institute, Celgene (United States)

OpenAlex ID: A5049343249

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

2006 · Paul G. Richardson, Emily Blood, et al. · Blood · 523

Works count: 1

Citation count: 523

H-index: 1

I10-index: 1